1. Structure activity relationship of various bisphosphonates;Shinoda, H.; Adamek, G.; Felix, R.; Fleisch, H.; Hagen, Schenk R.; P.;Calcif Tissue Int,1983
2. A single infusion of the bisphosphonate AHPrBP (APD) as a treatment of Paget's disease of bone;Thiebaud, D.; Jaeger, P.; Gobelet, C.; F, Jacquet A.; Burckhardt, P.;Am Med,1988
3. Absorption of oral diphosphonates in normal subjects;Fogelman, I.; Smith, L.; Mazess, R.; A, Wilson M.; A, Bevan J.;Clin Endocrinol (Oxf),1986
4. Low dose intravenous 3-aminohydroxypropylidene-1,1 -bisphosphonate (APD) for the treatment of Paget's disease of bone;A, Cantrill J.; M, Buckler H.; C, Anderson D.;Ann Rheuni Dis,1986
5. Bijvoet 0 L M. Paget's disease of bone: early and late responses to three different modes of treatment;J, Harinck H.I.; E, Papapolous S.; J, Blanksma H.; J, Moolenaar A.; P, Vermeij;BMJ,1987